Table 4.

Sequences of primers and probes used for clonotypic assays


Probes

Primers
Quantitative clonotypic assays*  
   jb1-1FAM   FAM-CAAGGCACCAGACTCACAGT-BHQ-1  
   jb2-1FAM   FAM-AGCAGTTCTTCGGGCCAG-MGBNFQ  
   jb2-3FAM   FAM-CAGTATTTTGGCCCAGGCA-MGBNFQ  
   vb12jb2.3BM sense, patient no. 31   5′-AGTTATGGAGCGGGGGCTAGCAC-3′  
   vb13jb2.3BM sense, patient no. 37   5′-AGTTCCATCGGAAGGACTAGTAC-3′  
   vb6jb2.3PB sense, patient no. 39   5′-TGCGTATCCACCGGAGGAGAG-3′  
   vb14jb2.3BM sense, patient no. 40   5′-AGCAGGGAGACTAGCGGTCACAC-3′  
   vb23jb2.1PB sense, patient no. 40   5′-CATTGATTCCCTGTCCCGGGAAG-3′  
   vb15jb2.3PB sense, patient no. 41   5′-CTGCGTATCTGTGTCCCCTGTCC-3′  
   vb24jb2.5PB sense, patient no. 41   5′-GGTCTCTCCTCCTACTCTGC-3′  
   vb7jb2.1PB sense, patient no. 42   5′-TGTAAGGGTAGGCCCCGGTG-3′  
   CB antisense   5′-CTGCTTCTGATGGCTCAAACAC-3′  
Clonotypic PCR assays on biopsy tissues  
   vb6 sense   5′-TCTCAGGTGTGATCCAAATTCGGG-3′  
   vb7 sense   5′-CCTGAATGCCCCAACAGCTCTCTC-3′  
   vb15 sense   5′-CAGGCACAGGCTAAATTCTCCCTG-3′  
   vb23 sense   5′-GCAGGGTCCAGGTCAGGACCCCCA-3′  
   vb24 sense   5′-CCCAGTTTGGAAAGCCAGTGACCC-3′  
   vb6jb2.3PB antisense, patient no. 39   5′-TGCGTATCCACCGGAGGAGAG-3′  
   vb23jb2.1PB antisense, patient no. 40   5′-CATTGATTCCCTGTCCCGGGAAG-3′  
   vb15jb2.3PB antisense, patient no. 41   5′-CTGCGTATCTGTGTCCCCTGTCC-3′  
   vb24jb2.5PB antisense, patient no. 41   5′-GGTCTCTCCTCCTACTCTGC-3′  
   vb7jb2.1PB antisense, patient no. 42   5′-TGTAAGGGTAGGCCCCGGTG-3′  
   jb2.1 antisense   5′-CCTTCTTACCTAGCACGGTGA-3′  
   jb2.3 antisense   5′-CCCGCTTACCGAGCACTGTCA-3′  
   jb2.5 antisense
 
5′-CGCGCACACCGAGCAC-3′
 

Probes

Primers
Quantitative clonotypic assays*  
   jb1-1FAM   FAM-CAAGGCACCAGACTCACAGT-BHQ-1  
   jb2-1FAM   FAM-AGCAGTTCTTCGGGCCAG-MGBNFQ  
   jb2-3FAM   FAM-CAGTATTTTGGCCCAGGCA-MGBNFQ  
   vb12jb2.3BM sense, patient no. 31   5′-AGTTATGGAGCGGGGGCTAGCAC-3′  
   vb13jb2.3BM sense, patient no. 37   5′-AGTTCCATCGGAAGGACTAGTAC-3′  
   vb6jb2.3PB sense, patient no. 39   5′-TGCGTATCCACCGGAGGAGAG-3′  
   vb14jb2.3BM sense, patient no. 40   5′-AGCAGGGAGACTAGCGGTCACAC-3′  
   vb23jb2.1PB sense, patient no. 40   5′-CATTGATTCCCTGTCCCGGGAAG-3′  
   vb15jb2.3PB sense, patient no. 41   5′-CTGCGTATCTGTGTCCCCTGTCC-3′  
   vb24jb2.5PB sense, patient no. 41   5′-GGTCTCTCCTCCTACTCTGC-3′  
   vb7jb2.1PB sense, patient no. 42   5′-TGTAAGGGTAGGCCCCGGTG-3′  
   CB antisense   5′-CTGCTTCTGATGGCTCAAACAC-3′  
Clonotypic PCR assays on biopsy tissues  
   vb6 sense   5′-TCTCAGGTGTGATCCAAATTCGGG-3′  
   vb7 sense   5′-CCTGAATGCCCCAACAGCTCTCTC-3′  
   vb15 sense   5′-CAGGCACAGGCTAAATTCTCCCTG-3′  
   vb23 sense   5′-GCAGGGTCCAGGTCAGGACCCCCA-3′  
   vb24 sense   5′-CCCAGTTTGGAAAGCCAGTGACCC-3′  
   vb6jb2.3PB antisense, patient no. 39   5′-TGCGTATCCACCGGAGGAGAG-3′  
   vb23jb2.1PB antisense, patient no. 40   5′-CATTGATTCCCTGTCCCGGGAAG-3′  
   vb15jb2.3PB antisense, patient no. 41   5′-CTGCGTATCTGTGTCCCCTGTCC-3′  
   vb24jb2.5PB antisense, patient no. 41   5′-GGTCTCTCCTCCTACTCTGC-3′  
   vb7jb2.1PB antisense, patient no. 42   5′-TGTAAGGGTAGGCCCCGGTG-3′  
   jb2.1 antisense   5′-CCTTCTTACCTAGCACGGTGA-3′  
   jb2.3 antisense   5′-CCCGCTTACCGAGCACTGTCA-3′  
   jb2.5 antisense
 
5′-CGCGCACACCGAGCAC-3′
 

FAM-labeled and minor groove binder (MGB) or black hole quencher 1 (BHQ1) quenched probes were used for quantitative PCR. CB reverse primer was designed to cover both CB1 and CB2 chains

PB indicates primer designed from CDR3 sequence detected in peripheral blood; and BM, primer designed from BM-derived clonotype

*

Shown in Figure 4A, C 

Shown in Figure 4B 

or Create an Account

Close Modal
Close Modal